NCT00168233View on ClinicalTrials.gov

Impact of HIV and Its Treatment on Reverse Cholesterol Transport

CompletedOBSERVATIONAL
Enrollment

44

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

September 30, 2010

Study Completion Date

March 31, 2011

Conditions
HIV Infections
Trial Locations (1)

3004

Alfred Hospital and Baker Heart Research Institute, Melbourne

All Listed Sponsors
collaborator

National Health and Medical Research Council, Australia

OTHER

lead

The Alfred

OTHER

NCT00168233 - Impact of HIV and Its Treatment on Reverse Cholesterol Transport | Biotech Hunter | Biotech Hunter